We recently published 10 Stocks Jim Cramer Talked About. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer ...

(Reuters) -Abbott will buy cancer test maker Exact Sciences in a deal valued at up to $23 billion, including debt, marking ...

Exact Sciences, which bought Bay Area cancer testing pioneer Genomic Health in 2019, is projected to generate more than $3 ...

Abbott has signed a definitive agreement to acquire all of Exact Sciences’ outstanding shares for an estimated enterprise ...

Abbott's $23B Exact Sciences deal adds short-term risk and earnings dilution. Click here to read what this means for ABT ...

Nvidia stock turns lower as strong earnings fail to ease concerns over an artificial-intelligence bubble. The broader stock ...

Exact Sciences (EXAS) stock surges as Abbott Laboratories (ABT) agrees to acquire the company in a $21B all-cash acquisition.

Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test maker Exact Sciences Corp , Bloomberg ...

The deal appears to be the biggest healthcare acquisition announced this the year, and would be Abbott’s largest since 2017.

Abbott Laboratories agreed to acquire cancer-screening company Exact Sciences Corp., in a deal with a total equity value of ...

As of 2:30 p.m. EST, Exact Sciences' stock price was up more than 17%. Under the terms of the deal, Exact Sciences' ...

Shares of cancer diagnostic specialist Exact Sciences (NASDAQ: EXAS) rallied 50.7% this week through Thursday at 3:30 PM EDT.